🇺🇸 FDA
Patent

US 8835378

Multi-domain amphipathic helical peptides and methods of their use

granted A61KA61K38/00A61P

Quick answer

US patent 8835378 (Multi-domain amphipathic helical peptides and methods of their use) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Sep 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K38/00, A61P, A61P29/00, A61P3/00